Oncology

Latest News

Top 5 Most-Read Oncology Content of 2024

December 25th 2024

This year’s most-read oncology content of 2024 includes topics on clinical trials, drug access, vaping and lung cancer, and more!

Most Popular Articles of 2024 in Evidence-Based Oncology

By Mary Caffrey

December 23rd 2024

ICYMI: Highlights From ASCO 2024

By Pearl Steinzor

December 21st 2024

chemotherapy | Image credit: Penn Medicine

The High Cost of Shortages of Low-Cost Chemotherapy

By Interview by Mary Caffrey

December 19th 2024

Leukemia diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Real-World Treatment Sequences and Cost Analysis of cBTKis in CLL

By Pearl Steinzor

December 17th 2024

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

April 7th 2016

ICER to Evaluate Value of Amgen's Multiple Myeloma Treatment

Surabhi Dangi-Garimella, PhD

Drug developer Amgen is questioning the assessment of its multiple myeloma treatments at the hands of the Institute for Clinical and Economic Review.

April 7th 2016

Chemotherapy With Radiation Can Improve Outcomes in Glioma Patients

Surabhi Dangi-Garimella, PhD

Patients with grade 2 glial brain tumors (gliomas) who were treated with radiation therapy (RT) and chemotherapy had a longer progression-free survival and overall survival than those who received RT alone.

April 6th 2016

Hypofractionated Radiotherapy Could Improve QoL and Be Cost-Effective in Prostate Cancer

Surabhi Dangi-Garimella, PhD

In men with low-risk prostate cancer, hypofractionation is non-inferior than the standard treatment dose and has the potential for saving treatment costs, according to a new study in the Journal of Clinical Oncology.

April 5th 2016

Physician Bias in Shared Decision Making - Can It Be Resolved?

Surabhi Dangi-Garimella, PhD

April 5th 2016

FDA's Califf Tells Fellow Cardiologists How Precision Medicine Can Reshape Clinical Trials

Mary Caffrey

The nation's top food and drug regulator enjoyed a warm welcome from colleagues on the final day of the 65th Scientific Session of the American College of Cardiology.

April 5th 2016

Cancer Care Has Not Overtaken Overall Healthcare Costs, Clarifies Milliman Study

Surabhi Dangi-Garimella, PhD

The study, commissioned by the Community Oncology Alliance, has found that overall costs for Medicare and commercial health plan enrollees have been increasing at the same rate as the cost of treating patients with cancer. This contradicts the popular notion that cancer care costs have far outpaced overall healthcare spending.

April 5th 2016

The Promise of Cancer Immunotherapy: Why Patient Education Is Critical, Part II

Debra Madden

It is imperative that we gather more mature data on a much larger number of patients to accurately assess efficacy, safety, potential harms, durability of response, and impact on disease progression and overall survival of the new immunotherapy treatments.

April 4th 2016

Successful Intervention Improved Breast Cancer Screening Rates Among Latinos

Surabhi Dangi-Garimella, PhD

A new study by researchers at the Kaiser Permanente Center for Health Research has found that visits by trained community health workers improved screening rates for breast cancer among Latino women.

April 2nd 2016

The Politics of Cancer Care in 2016

Surabhi Dangi-Garimella, PhD

Four panelists and 2 moderators discussed the issues surrounding cancer and healthcare in the lead-up to the 2016 presidential election during the National Comprehensive Cancer Network 21st Annual Conference.

April 2nd 2016

Dr John Thompson Outlines Updates in Melanoma

John A. Thompson, MD, co-director of the Melanoma Clinic at the Seattle Cancer Care Alliance, highlighted the major points of his melanoma talk at the National Comprehensive Cancer Network’s 21st Annual Meeting, including the FDA approval of new drugs and the development of new viral therapies.

April 2nd 2016

Dr Lee Schwartzberg on Updates in Managing Breast Cancer in Older Women

There are a number of lessons oncologists have learned as the population of women who were diagnosed with breast cancer at a younger age grow older, said Lee Schwartzberg, MD, FACP, chief of Division of Hematology Oncology and professor of medicine at the University of Tennessee Health Science Center.

April 1st 2016

NCCN Has Faith in the Potential of Biosimilars

Surabhi Dangi-Garimella, PhD

While these "generic" biologicals have been deemed to have the potential to create competition and result in healthcare savings-although not to the extent of generic products-technical issues with manufacturing these products have troubled drug manufacturers.

April 1st 2016

Despite Progress, CRC Remains Hard-to-Treat Says Expert at NCCN

Surabhi Dangi-Garimella, PhD

At the National Comprehensive Cancer Network (NCCN) 21st Annual Conference, Alan P. Venook, MD, professor of Clinical Medicine at the University of California, San Francisco, provided insight into lessons learned by oncologists in the treatment of colorectal cancer.

April 1st 2016

Dr Pamela Becker Says the US Is "Just Scratching the Surface" for Biosimilars

Now that 1 biosimilar has made it to market in the United States, Pamela S. Becker, MD, PhD, professor of medicine in the Division of Hematology at the University of Washington School of Medicine, expects more to follow and that, hopefully, biosimilars will help achieve cost savings for healthcare.

April 1st 2016

Dr Robert Carlson on Calculating Value in Cancer Care

Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network (NCCN), discussed calculating value in cancer care and the dimensions of NCCN's value assessment framework, Evidence Blocks.

April 1st 2016

Weighing Value and Patient Preference in Cancer Care: NCCN Evidence Blocks

Surabhi Dangi-Garimella, PhD

At the National Comprehensive Cancer Network (NCCN)'s 21st Annual Conference, Robert Carlson, MD, chief executive officer, NCCN, provided a flavor for their value framework, the Evidence Blocks.

March 31st 2016

NCCN Melanoma Guideline Update: It's About Immunotherapy and Targeted Therapy

Surabhi Dangi-Garimella, PhD

At the National Comprehensive Cancer Network 21st Annual Conference, John A. Thompson, MD, presented an update on where the field of melanoma treatment stands today.

March 31st 2016

Dr Sophia Smith Advocates for Introducing Palliative Care as Early as Possible

Palliative care should be introduced as early as possible, even as early as diagnosis, so patients hear about it early and not during a late stage of their disease when they might need hospice, Sophia K. Smith, PhD, MSW, associate professor at the Duke School of Nursing, said at the National Comprehensive Cancer Network Annual Meeting.

March 31st 2016

Dr Toby Campbell: High-Quality Cancer Care Includes Palliative Care

High-quality cancer care must include palliative care in addition to the more traditional care, such as oncology, radiology, surgery, and imaging, Toby C. Campbell, MD, MSCI, associate professor of medicine, hematology-oncology at the University of Wisconsin School of Medicine and Public Health and chief of Palliative Care and program director of the Hospice and Palliative Medicine Fellowship Training Program, said at the National Comprehensive Cancer Network Annual Conference.

March 31st 2016

Patient and Provider Perspectives on Palliative Care Discussed at NCCN

Surabhi Dangi-Garimella, PhD

During the opening session at the National Comprehensive Cancer Network 21st Annual Conference, healthcare providers came together to discuss palliation from the provider and the patient perspective.

March 30th 2016

A Recommendation for Combining Smoking Cessation Intervention With Lung Cancer Screening

Surabhi Dangi-Garimella, PhD

The Society for Research on Nicotine and Tobacco and the Association for the Treatment of Tobacco Use and Dependence have developed a position statement recommending access to smoking cessation interventions for smokers in the high-risk group who undergo a lung cancer screen.

March 30th 2016

Fever, Neutropenia Are Most Common Causes for Hospitalization of Children With Cancer

Priyam Vora

Among pediatric patients with cancer, fever and neutropenia continue to be a common and potentially life-threatening complication of chemotherapy.

March 29th 2016

Repurposing Statins for Treatment of Ovarian Cancer

AJMC Staff

A study presented at the 47th Society of Gynecologic Oncology meeting held in San Diego, found that women with ovarian cancer who received statin therapy in tandem with their cancer treatment had better survival.

March 29th 2016

Legislators Urge HHS and NIH to Intervene With the Price of Enzalutamide

Surabhi Dangi-Garimella, PhD

Pointing out that high drug prices are access barriers, the Congressmen have urged the government agencies to hold a public hearing to address the issue.

March 29th 2016

The Promise of Cancer Immunotherapy: Why Patient Education Is Critical, Part I

Debra Madden

March 28th 2016

Hospital Stay Did Not Improve Survival Among Terminal Cancer Patients in Japan

Surabhi Dangi-Garimella, PhD

A study among terminal cancer patients in Japan found that those with a prognosis of days or weeks survived longer when cared for at home.

March 26th 2016

This Week in Managed Care: March 26, 2016

This week's top managed care stories include a lawsuit between Anthem and Express Scripts, trouble with Medicare's bidding program for diabetes test strips, and the cost of reporting quality measurements.

March 25th 2016

Drug Manufacturers Lack in Oncology Provider Engagement

Surabhi Dangi-Garimella, PhD

In a survey conducted by a sales and marketing firm, oncologists, oncology nurses, and oncology administrators have expressed displeasure with the customer experience rendered by oncology manufacturers.

March 24th 2016

Oncotype DX Test for Breast Cancer Finds Clinical Acceptance, but Disparity Exists

Surabhi Dangi-Garimella, PhD

A retrospective research study has identified disparity in the use of the test, primarily driven by race, insurance status, and the type of facility where treatment was administered.

March 23rd 2016

Chemotherapy's Lasting Impact on Male Fertility in Childhood Cancer Survivors

Surabhi Dangi-Garimella, PhD

A new study from the Fred Hutchinson Cancer Research Center has found that boys who underwent chemotherapy to treat their cancer were less likely to father children.

...

101 102 103 104 105 106 107 108 109

...

181 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions